Cannabinoids for substance use disorder treatment: What does the current evidence say?

JAB Fernandes, R Filev, TM Fidalgo - Cannabis and Cannabinoid …, 2023 - liebertpub.com
Background: The prevalence of Substance Use Disorder (SUD) is increasing along with the
need to develop approaches to reduce the harm associated with substance use, including …

[HTML][HTML] Kratom use within the context of the evolving opioid crisis and the COVID-19 pandemic in the United States

WC Prozialeck, PC Lamar, M Krupp, M Moon… - Frontiers in …, 2021 - frontiersin.org
Kratom (Mitragyna speciosa, Korth.) is an evergreen tree that is indigenous to Southeast
Asia. When ingested, kratom leaves or decoctions from the leaves have been reported to …

Cannabis use to manage opioid cravings among people who use unregulated opioids during a drug toxicity crisis

H Reddon, S Lake, ME Socias, K Hayashi… - International Journal of …, 2023 - Elsevier
Background Accumulating evidence has indicated that cannabis substitution is often used
as a harm reduction strategy among people who use unregulated opioids (PWUO) and …

The impact of cannabis on non-medical opioid use among individuals receiving pharmacotherapies for opioid use disorder: a systematic review and meta-analysis of …

GPA Costa, JC Nunes, DL Heringer… - The American Journal …, 2024 - Taylor & Francis
Background: The relationship between cannabis use and the risk of returning to using
opioids non-medically during treatment for opioid use disorder (OUD) remains unclear …

[HTML][HTML] Cannabis donation as a harm reduction strategy: a case study

SE Duhart Clarke, G Victor, P Lynch, LW Suen… - Harm reduction …, 2024 - Springer
Abstract Background The United States (US) continues to experience unprecedented rates
of overdose mortality and there is increased need to identify effective harm reduction …

Impact of fentanyl use on initiation and discontinuation of methadone and buprenorphine/naloxone among people with prescription‐type opioid use disorder …

ME Socias, E Wood, B Le Foll, R Lim, JC Choi… - …, 2022 - Wiley Online Library
Background and aims Fentanyl is primarily responsible for the current phase of the overdose
epidemic in North America. Despite the benefits of treatment with medications for opioid use …

Characteristics of adults reporting illicitly manufactured fentanyl or heroin use or prescription opioid misuse in the United States, 2019

X Jiang, GP Guy Jr, C Dunphy, CM Pickens… - Drug and alcohol …, 2021 - Elsevier
Background Deaths involving illicitly manufactured fentanyl (IMF) have increased since
2013 in the United States. Little research has examined individuals using IMF. This study …

Indirect effects of emotion regulation in the relationship between pain and cannabis use in adults 18-64 years

TS Schepis, AH Rogers, L Munoz, MJ Zvolensky - Addictive Behaviors, 2024 - Elsevier
Introduction Individuals with chronic pain often receive prescription opioid medication, and
they may use cannabis to treat pain as well, although the risks of cannabis-opioid co-use are …

[HTML][HTML] Denial of prescription pain medication among people who use drugs in Vancouver, Canada

EM Piret, MJ Milloy, P Voon, JC Choi, K DeBeck… - Harm Reduction …, 2024 - Springer
Background People who use drugs experience pain at two to three times the rate of the
general population and yet continue to face substantial barriers to accessing appropriate …

Longitudinal polysubstance use patterns and non-fatal overdose: a repeated measures latent class analysis

M Karamouzian, Z Cui, K Hayashi, K Debeck… - International Journal of …, 2024 - Elsevier
Background Polysubstance use (PSU) is common among people who use opioids (PWUO)
and has been associated with drug-related harms. We aimed to identify latent longitudinal …